Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Bayer
company
About
Bayer is a life science company that specializes in the areas of health care and agriculture.
- Leverkusen,Nordrhein-Westfalen,Germany
- 10001 - max
- https://www.bayer.com
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $12M
- Industries
- Biotechnology,Chemical,Health Care,Life Science,Pharmaceutical
- Founded date
- Jan 1, 1863
- Number Of Employee
- 10001 - max
- Operating Status
- Active
- Stock Symbol
- etr:BAYN
- Legal Name
- Bayer AG
- Sub-Organizations
-
Bayer Open Innovation
Bayer is an enterprise with core competencies in the life science fields of healthcare and nutrition. They design their products and services to help people and the planet thrive by supporting efforts to address unprecedented challenges. Their businesses include pharmaceuticals, consumer health, and crop science. They focus on developing and commercializing products and solutions based on scientific knowledge.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$12M €3B
Bayer has raised a total of
$12M €3B
in funding over 2 rounds. Their latest funding was raised on
Nov 8, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 8, 2022 | Grant | $12M | 1 |
Bill & Melinda Gates Foundation
|
— | Detail |
| Apr 17, 2018 | Post-IPO Equity | €3B | 1 |
Temasek Holdings
|
— | Detail |
| Oct 2, 2009 | IPO | — | — | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
30
13
Bayer has made 30 investments. Their most recent investment was on
Jun 20, 2022, when OME Health raised 0.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 20, 2022
OME Health
|
Seed | — | Analytics | — |
|
Mar 1, 2021
Grão Direto
|
Series Unknown | R$18M | Agriculture | — |
|
Nov 17, 2020
Elly
|
Series Unknown | — | Health Care | — |
|
Aug 24, 2020
OneDrop
|
Series C | $34.70M | Apps | Yes |
|
Feb 27, 2020
Oerth Bio
|
Corporate Round | $55M | Biotechnology | — |
Investors
Number of Lead Investors
Number of Investors
2
2
Bayer is funded by 2 investors.
Bill & Melinda Gates Foundation
and Temasek Holdings
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Bill & Melinda Gates Foundation
|
Yes | Grant |
|
Temasek Holdings
|
Yes | Post-IPO Equity |
Employee Profiles
Number of Employee Profiles
61
Bayer has 61 current employee profiles, including
Employee Kate Humphrey
Employee
Executive
Executive
Executive
Employee
Exits
Bayer has had 2 exits. Bayer most notable exits include Covercress , BlueRock Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Aug 1, 2022 | Covercress | M&A | Animal Feed | Detail |
| Aug 8, 2019 | BlueRock Therapeutics | M&A | Biopharma | Detail |
Acquisition
Bayer has acquired 16 organizations. Their most recent acquisition was Zeptosens on Mar 9, 2005. They acquired Zeptosens for 0.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Mar 9, 2005
Zeptosens
|
Biotechnology | — | — | Detail |
|
Feb 13, 2006
Icon Genetics
|
Agriculture | — | — | Detail |
|
Mar 11, 2010
Artificial Muscle Inc.
|
Electronics | acquisition | — | Detail |
|
Jul 1, 2012
AgraQuest
|
Agriculture | acquisition | $ 425M | Detail |
|
Dec 19, 2013
Algeta
|
Biotechnology | acquisition | $ 2.90B | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
